In an environment where the cost of inaction eclipses the cost of innovation, evaluating the ROI of risk reduction technology is a critical skill for enterprise leaders. Although enterprise risk is ...

"Pneumococcal infections are a leading cause of death globally…This overview helps to prioritize areas for prevention of pneumococcal disease." — Amelieke JK Cremers, MD, PhD, Department of ...

EDITOR’S NOTE: The podcast Chasing Life With Dr. Sanjay Gupta explores the medical science behind some of life’s mysteries big and small. You can listen to episodes here. The “Shaking Palsy.” Those ...

PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical, Co. Ltd. (Otsuka) today announce the U.S. Food and Drug Administration ...

Daniel Byrne and Ted Bouthiller Jr. offer a remedy for overloaded fire inspectors: include basic fire code instruction in firefighter training to put more eyes and ears on the ground for reducing ...

Oftentimes, first responders are in reaction mode when they respond to incidents. They typically arrive at a scene and assess what needs to be done. But a couple of classes are bringing together Lower ...

A cardiologist recently suggested that I should consider taking a statin because of my “borderline” cholesterol level. So, I took a dive into the details of statin therapy. I learned that although ...

Joby Aviation is upgraded to Buy, reflecting its relative strength and lower execution risks versus Archer Aviation. JOBY leads in operational milestones, including advanced FAA certification, early ...

(RTTNews) - Amgen (AMGN) announced detailed findings from its Phase 3 VESALIUS-CV clinical trial, revealing that Repatha (evolocumab) significantly reduces major adverse cardiovascular events (MACE) ...

THOUSAND OAKS, Calif., Nov. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced detailed results from the Phase 3 VESALIUS-CV clinical trial, which showed that Repatha® (evolocumab) achieved ...